Medtronic's plans to separate its combined patient monitoring and respiratory interventions businesses will likely go forward, Seeking Alpha reported June 12.
The planned spinoff will allow for greater investment focus in the areas of "highest strategic priority" and help execute Medtronic's leadership strategy in attractive medtech markets, the company said in an October.
Discussions with Carlyle Group, a private equity firm, have slowed, the report said. The devicemaker was looking to sell the businesses for about $10 billion.